SHOULDER INNOVATIONS, INC.SIEarnings & Financial Report
Shoulder Innovations, Inc. is a medical technology firm specializing in design, development, and commercialization of innovative orthopedic devices for shoulder replacement surgery. Its products reduce surgical complications, improve patient outcomes, and are sold to orthopedic surgeons and healthcare providers across North America and Western Europe.
SI Q3 FY2025 Key Financial Metrics
Revenue
$11.8M
Gross Profit
$9.0M
Operating Profit
$-7.6M
Net Profit
$-8.7M
Gross Margin
76.2%
Operating Margin
-65.0%
Net Margin
-74.3%
YoY Growth
N/A
EPS
$-0.64
SHOULDER INNOVATIONS, INC. Q3 FY2025 Financial Summary
SHOULDER INNOVATIONS, INC. reported revenue of $11.8M for Q3 FY2025, with a net profit of $-8.7M (-74.3% margin). Cost of goods sold was $2.8M, operating expenses totaled $16.6M.
Key Financial Metrics
| Total Revenue | $11.8M |
|---|---|
| Net Profit | $-8.7M |
| Gross Margin | 76.2% |
| Operating Margin | -65.0% |
| Report Period | Q3 FY2025 |
SHOULDER INNOVATIONS, INC. Quarterly Revenue & Net Profit History
SHOULDER INNOVATIONS, INC. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $11.8M | — | $-8.7M | -74.3% |
| Q2 FY2025 | $11.0M | — | $-19.2M | -174.3% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $11.0M | $11.8M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $77.8M | $177.8M |
| Liabilities | $29.3M | $29.9M |
| Equity | $-78.2M | $147.8M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-11.3M | $-8.6M |